These drugs work similarly but differ in dosage and specific indications (uses). Research suggests that tirzepatide is more ...

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...